Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma

Table 2 CTTN relative magnitude of the three groups

Group	n	$\bar{x}$ ± SE	Minimal value	Maximal value	95%CI
Control	20	6.54 ± 0.96	1.00	15.72	4.53-8.56
No cancer embolus and metastasis	52	7.75 ± 0.70	1.15	20.35	6.34-9.16
Cancer embolus or metastasis	25	19.73 ± 2.02	2.99	42.47	15.56-23.90

Levene test of homogeneity of variance: F = 10.57, P <0.001; Kruskal-Wallis H test: H = 31.13, P <0.001.

ISSN: 1477-7819